RLYB

NASDAQStock

Rallybio Corporation

$9.45-0.15 (-1.56%)

52-Week Range

$2.00

$10.97

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

-1.13

Volume

88.9K

Avg Volume

419.1K

Performance

+101.26%

+55.99%

+102.22%

YTD

+69.66%

+89.87%

-76.00%

-92.94%

Price Chart

ETF Exposure

RLYB is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	31	$27	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,116	$970	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	5	$4	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	635,767	$408K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	3,344	$3K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	288	$250	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	260,565	$167K	$84.10B	0.05%

About RLYB ETF Exposure

Rallybio Corporation (RLYB) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $9.45. Investors can gain exposure to RLYB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RLYB, sorted by portfolio weight.